Ruff K. Exposé of the International Chrysotile Association: The International Chrysotile Association Continues Its Deadly Work Around The World 2013 [Available from: https://rightoncanada.ca/?p=1862.
Ruff K. Scientists ask Quebec government to stop deadly misconduct by international asbestos lobby based in Quebec 2019 [Available from: https://rightoncanada.ca/?p=4400.
Welch LS. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan supreme court. Int J Occup Environ Health. 2007;13(3):318–27.
Baur X, Soskolne CL, Lemen RA, Schneider J, Woitowitz HJ, Budnik LT. How conflicted authors undermine the World Health Organization (WHO) campaign to stop all use of asbestos: spotlight on studies showing that chrysotile is carcinogenic and facilitates other non-cancer asbestos-related diseases. Int J Occup Environ Health. 2015;21(2):176–9.
Egilman D, Fehnel C, Bohme SR. Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med. 2003;44(5):540–57.
Lemen RA. Asbestos in brakes: exposure and risk of disease. Am J Ind Med. 2004;45(3):229–37.
Egilman D, Howe S. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology. Int J Occup Environ Health. 2007;13(1):118–24.
Bernstein DM. The health risk of chrysotile asbestos. Curr Opin Pulm Med. 2014;20(4):366–70.
Roggli VL. The so-called short-fiber controversy: literature review and critical analysis. Archives of pathology & laboratory medicine. 2015;139(8):1052–7.
Ruff K. Scientific journals and conflict of interest disclosure: what progress been made? Environmental Health [Internet]. 2015; 14(45). Available from: http://dx.doi.org/https://doi.org/10.1186/s12940-015-0035-6.
Affidavit of Arthur L. Frank, State of Pennsylvania County of Philadelphia [Internet]. State of Pennsylvania County of Philadelphia. 2016. Available from: https://drexel.edu/dornsife/academics/faculty/Arthur%20Frank/.
Ruff K. Longtime asbestos industry consultant, David Bernstein, discloses his industry ties 2014 [Available from: https://rightoncanada.ca/?p=2672.
Gilham C, Rake C, Burdett G, Nicholson AG, Davison L, Franchini A, et al. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med. 2016;73(5):290–9.
Ruff K. Asbestos lobby hopes to block asbestos bans with its bought science 2017 [Available from: https://rightoncanada.ca/?p=3926.
Barrett JC. Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence. Environ Health Perspect. 1994;102(Suppl 5):19–23.
Egilman D, Baur X, Soskolne CL. Unreliable proposed 'new standard' for assessing asbestos exposure. Occup Environ Med. 2016;73(10):709.
Baker DB. Limitations in drawing etiologic inferences based on measurement of asbestos fibers from lung tissue. Ann N Y Acad Sci. 1991;643:61–70.
Churg A, Wright JL. Persistence of natural mineral fibers in human lungs: an overview. Environ Health Perspect. 1994;102(Suppl 5):229–33.
Dodson RF, Hammar SP, Poye LW. A technical comparison of evaluating asbestos concentration by phase-contrast microscopy (PCM), scanning electron microscopy (SEM), and analytical transmission electron microscopy (ATEM) as illustrated from data generated from a case report. Inhal Toxicol. 2008;20(7):723–32.
Finkelstein MM, Dufresne A. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. 1999;35(4):401–12.
Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of north American insulation workers. Ann N Y Acad Sci. 1991;643:27–52.
Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci. 2002;982:160–76.
Wagner JC, Berry G, Pooley FD. Mesotheliomas and asbestos type in asbestos textile workers: a study of lung contents. Br Med J. 1982;285(6342):603–6.
Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005;208(3):201–10.
Abraham JL. Analysis of fibrous and non-fibrous particles. Environmental and occupational medicine, 4th edition. Philadelphia, USA: Lippincott Williams and Wilkins; 2006. p. 277–97.
Dodson RF, Atkinson MA, Levin JL. Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med. 2003;44(3):291–7.
Egilman D, Bird T. Short fiber tremolite free chrysotile mesothelioma cohort revealed. Am J Ind Med. 2016;59(3):196–9.
McCormack V, Peto J, Byrnes G, Straif K, Boffetta P. Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Br J Cancer. 2012;106(3):575–84.
Lemen RA, Frank AL, Soskolne CL, Weiss SH, Castleman B. Comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality' - IARC and chrysotile risks. Br J Cancer. 2013;109(3):823–5.
Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-Asbestos causes. Archives of pathology & laboratory medicine. 2018;142(6):753–60.
Gallateau-Salle F, Churg A, Roggli VL, Attanoos R, Borczuk A, Cagle P, et al. Mesothelial tumours - Diffuse malignant mesothelioma - epithelioid mesothelioma.https://pwhdtrial.sharefile.com/d-s28cddf934ff4bd58 In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4 ed. Lyon: IARC/WHO; 2015. p. 156–64.
Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. The Annals of occupational hygiene. 2000;44(8):565–601.
Berman DW, Crump KS. Final draft: technical support document for a protocol to assess asbestos–related risk. EPA Report 9345.4~)6. Office of Solid Waste Emergency Response. EPA Report 93454–06 [Internet]. 2003. Available from: bwcase.tripod.com/atech1.pdf.
Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):1–47.
Frank AL, Dodson RF, Williams MG. Carcinogenic implications of the lack of tremolite in UICC reference chrysotile. Am J Ind Med. 1998;34(4):314–7.
Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982;45(1):124–35.
Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer. 1974;29(3):252–69.
Pott F, Huth F, Friedrichs KH. Tumorigenic effect of fibrous dust in experimental animals. Environ Health Perspect. 1974;9:313–5.
Pavlisko EN, Liu B, Green C, Sporn TA, Roggli VL. Malignant diffuse mesothelioma in women: a study of 354 cases. Am J Surg Pathol. 2020;44(3):293–304.
Marsh GM, Benson SM. Response to: 'Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment' by Ferrante et al. Occup Environ Med. 2017;74(2):156–7.
Lemen RA, Landrigan PJ. Toward an Asbestos Ban in the United States. Int J Environ Res Public Health. 2017;14(11).
Ferrante D, Mirabelli D, Tunesi S, Terracini B, Magnani C. Pleural mesothelioma and asbestos exposure: a case-control study with quantitative risk assessment-response to Marsh and Benson's letter. Occup Environ Med. 2017;74(2):157–8.
Lemen RA. Mesothelioma from asbestos exposures: epidemiologic patterns and impact in the United States. J Toxicol Environ Health B Crit Rev. 2016;19(5–6):250–65.
Azuma K, Uchiyama I, Chiba Y, Okumura J. Mesothelioma risk and environmental exposure to asbestos: past and future trends in Japan. Int J Occup Environ Health. 2009;15(2):166–72.
Davis JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 1986;67(3):415–30.
Roggli VL, Brody AR. Changes in numbers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res. 1984;7(2):133–47.
Yeager H Jr, Russo DA, Yanez M, Gerardi D, Nolan RP, Kagan E, et al. Cytotoxicity of a short-fiber chrysotile asbestos for human alveolar macrophages: preliminary observations. Environ Res. 1983;30(1):224–32.
Roggli VL. Testimony in the Case of Michelle and Joseph Zierer Vs. Advance Stores Company, Inc. 2015.
Deposition of Victor Louis Roggli: Hearing before the Circuit Court of Kanawha County West Virginia (October 20, 2015, 2015).
Egilman D. Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony. Int J Occup Environ Health. 2009;15(2):202–28.
Finkelstein MM. Asbestos fibre concentrations in the lungs of brake workers: another look. The Annals of occupational hygiene. 2008;52(6):455–61.
Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. Tremolite and mesothelioma. The Annals of occupational hygiene. 2002;46(5):447–53.
Lemen RA. Chrysotile asbestos and mesothelioma. Environ Health Perspect. 2010;118(7):A282.
Feder IS, Theile A, Tannapfel A. Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany. Int J Occup Med Environ Health. 2018;31(3):293–305.
Feder IS, Tischoff I, Theile A, Schmitz I, Merget R, Tannapfel A. The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J. 2017;49(6).
Baur X. Response to the letter of R. Merget, I. Feder and A. Tannapfel http://www.ncbi.nlm.nih.gov/pubmed/28222480. Pneumologie [internet]. 2017 Feb; 71(2):[121-3 pp.]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28222480.
Ruff K. Commentary on "The asbestos fibre burden in human lungs: new insights into the chrysotile debate" by Federet al. in press. 2019.
Oliver LC, Belpoggi F, Budnik LT, Egilman D, Frank AL, Mandrioli D, et al. Correspondence regarding the article "The asbestos fibre burden in human lungs: new insights into the chrysotile debate". Eur Respir J. 2017;50(6).
Baur X, Belpoggi F, Budnik LT, Casteleyn L, Frank AL, Oliver LC, et al. Letter to the editor (February 14, 2018) concerning the paper "histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". Int J Occup Med Environ Health. 2018;31(6):837–9.
Woitowitz HJ, Baur X. Misleading "new insights into the Chrysotile debate". Pneumologie. 2018;72(7):507–13.
Landrigan PJ, Lemen RA, Collegium RO. Letter to the editor (April 4, 2018) concerning the paper "histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". Int J Occup Med Environ Health. 2018;31(6):845–7.
Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis- an update of the diagnostic criteria: report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Archives of pathology & laboratory medicine. 2010;134(3):462–80.
Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5–15.
Case No. 793085 Plaintiffs, −v- Ammco Tools, Inc., et al.,Defendants. Transcript of proceedings, April 18, 2014. The Court of Common Pleas, Civil Division. The State of Ohio, County of Cuyahoga; 2014.
Baur X. Asbestos: socio-legal and scientific controversies and unsound science in the context of the worldwide Asbestos tragedy - lessons to be learned. Pneumologie. 2016;70(6):405–12.
Hammar SP, Abraham JL. Commentary on pathologic diagnosis of asbestosis and critique of the 2010 asbestosis Committee of the College of American pathologists (CAP) and pulmonary pathology Society's (PPS) update on the diagnostic criteria for pathologic asbestosis. Am J Ind Med. 2015;58(10):1034–9.
No. 63-CIV-2016-812-3. Hendrix K.A. vs. Akebond Brake Co, Et. Arkansas, USA: In the Circuit Court of Saline County, Arkansas City Division; 2018.
Baur X, Woitowitz HJ, Budnik LT, Egilman D, Oliver C, Frank A, et al. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. Am J Ind Med. 2017;60(5):411–21.
Egilman D, Tran T. A commentary on Roggli's "the so-called short-Fiber controversy". Int J Occup Environ Health. 2016;22(3):181–6.
Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26(2):55–65.
Schneider J, Arhelger R, Brueckel B. Lungenstaubanalysen in der Begutachtung asbestverursachter Erkrankungen. Zbl Arbeitsmed. 2015;65:305–9.
Schneider J, Arhelger R, Brueckel B. Leserbriefantwort zum Artikel Lungenstaubanalysen in der Begutachtung asbestverursachter Erkrankungen. Zbl Arbeitsmed. 2016;4:228–31.
Baur X, Woitowitz HJ. Lung Cancer as an occupational disease. Pneumologie. 2016;70(8):510–3.
La Vecchia C, Boffetta P. Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma. Eur J Cancer Prev. 2012;21(3):227–30.
Baur X, Terracini B, Belpoggi F, Budnik LT, Woitowitz HJ, Soskolne CL. Commentary to the article lung function not affected by asbestos exposure in workers with normal computed tomography scan, by Schikowsky, Felten, et al., 2017. Am J Ind Med. 2018;61(4):351–4.
Terracini B, Mirabelli D, Baur X, Landrigan PJ, Ramazzini C. Re: comments on the causation of malignant mesothelioma: rebutting the false concept that recent exposures to asbestos do not contribute to causation of mesothelioma. Am J Ind Med. 2016;59(12):1180–2.
Magnani C, Fubini B, Mirabelli D, Bertazzi PA, Bianchi C, Chellini E, et al. Pleural mesothelioma: epidemiological and public health issues. Report from the second Italian consensus conference on pleural mesothelioma. La Medicina del lavoro. 2013;104(3):191–202.
Egilman D, Bird T, Lee C. Dust diseases and the legacy of corporate manipulation of science and law. Int J Occup Environ Health. 2014;20(2):115–25.
Egilman DS, Bird T, Lee C. MetLife and its corporate allies: dust diseases and the manipulation of science. Int J Occup Environ Health. 2013;19(4):287–303.
Baur X, Budnik LT, Ruff K, Egilman DS, Lemen RA, Soskolne CL. Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health. Int J Occup Environ Health. 2015;21(2):172–5.
Greenberg DS. Science, money, and politics: political triumph and ethical erosion. Chicago: The University Chicago Press; 2001.
Baba A, Cook DM, McGarity TO, Bero LA. Legislating "sound science": the role of the tobacco industry. Am J Public Health. 2005;95(Suppl 1):S20–7.
Michaels D. The triumph of doubt: dark money and the science of deception. New York ,USA: Oxford University Press; 2020.
Pezerat H. Chrysotile biopersistence: the misuse of biased studies. Int J Occup Environ Health. 2009;15(1):102–6.
Bohme SR. Expression of concern: false claim to be free of conflicts in asbestos biopersistence debate. Int J Occup Environ Health. 2012;18(2):85–8.
Michaels D. Doubt is their product: how industry's assault on science threatens your health. New York, USA: Oxford University Press; 2008.
Ruff K. Asbestos industry sabotages UN Rotterdam Convention https://rightoncanada.ca/?p=4027May 4, 2017 accessed August 28, 2019.
Kazan-Allen L. The asbestos war. Int J Occup Environ Health. 2003;9(3):173–93.
Egilman D, Wallace W, Hom C. Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & co. Account Res. 1998;6(1–2):127–47.
Egilman DS, Reinert A. Corruption of previously published asbestos research. Arch Environ Health. 2000;55(1):75–6.
(WHO) TIPoCSIWHO. Environmental Health Criteria 203 - Chrysotile Asbestos. 1998.
IARC. asbestos (Chrysotile, Amosite, Crocidolite, Tremolite, Actinolite and Anthophyllite) http://monographs.iarc.fr/ENG/Monographs/vol100C/. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans [Internet]. 2012; 100C. A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts.
American Thoracic S. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691–715.
Loomis D, Dement J, Richardson D, Wolf S. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 2010;67(9):580–4.
IPCS. Environmental Health Criteria 203 Chrysotile Asbestos. WHO. 1998.
ATSDR. Public Health Statement for Asbestos https://www.atsdr.cdc.gov/PHS/PHS.asp?id=28&tid=42001 [cited 2001.
IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.http://www.iarc.fr/en/media-centre/iarcnews/2012/mono105-info.php. Lyon, France: WHO; 2012. Available from: http://www.iarc.fr/en/media-centre/iarcnews/2012/mono105-info.php.
IJPC. http://www.ijpc-se.org/documents/01.JPC-SE-Position_Statement_on_Asbestos-June_4_2012-Summary_and_Appendix_A_English.pdf. 2012.
Baur X, Schneider J, Woitowitz HJ, Velasco GM. Do adverse health effects of chrysotile and amphibole asbestos differ? Pneumologie. 2012;66(8):497–506.
Lenters V, Vermeulen R, Dogger S, Stayner L, Portengen L, Burdorf A, et al. A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposure-response relationships? Environ Health Perspect. 2011;119(11):1547–55.
Lenters V, Burdorf A, Vermeulen R, Stayner L, Heederik D. Quality of evidence must guide risk assessment of asbestos. The Annals of occupational hygiene. 2012;56(8):879–87.
Lemen RA. Chrysotile asbestos as a cause of mesothelioma: application of the hill causation model. Int J Occup Environ Health. 2004;10(2):233–9.
State of Massechusetts. County of Norfolk. Chrysotile Affidavit of David S. Egilman. 2011.
Ferrante D, Mirabelli D, Silvestri S, Azzolina D, Giovannini A, Tribaudino P, et al. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study. AJIM. 2019.
Mirabelli D, Calisti R, Barone-Adesi F, Fornero E, Merletti F, Magnani C. Excess of mesotheliomas after exposure to chrysotile in Balangero, Italy. Occup Environ Med. 2008;65(12):815–9.
Cullen M, Baloyi R. Chrysotile asbestos and health in Zimbabwe: I. analysis of miners and millers compensated for asbestos-related diseases since independence 1980. Am J Ind Med. 1991;19:161–9.
Sturm W, Menze B, Krause J, Thriene B. Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lets. 1994;72:317–24.
Robinson CF, Lemen RA, Wagoner JK. Mortality patterns, 1940–1975 among workers employed in an asbestos textile friction and packing products manufacturing facilities. In: Lemen RA, Dement JM, editors. Dust and disease. Park Forest, IL: Pathotox; 1979. p. 131–43.
Leigh J, Driscoll T. Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health. 2003;9:206.
Yano E, Wang ZM, Wang XR, Wang MZ, Lan YJ. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. Am J Epidemiol. 2001;154(6):538–43.
BAuA. National asbestos profile for Germany. https://www.baua.de/EN/Service/Publications/Report/Gd80.html 2014. Available from: https://www.baua.de/EN/Service/Publications/Report/Gd80.html
Bolton RE, Davis JM, Donaldson K, Wright A. Variations in the carcinogenicity of mineral fibres. The Annals of occupational hygiene. 1982;26(1–4):569–82.
Minardi F, Maltoni C. Results of recent experimental research on the carcinogenicity of natural and modified asbestos. Ann N Y Acad Sci. 1988;534:754–61.
Roller M, Pott F, Kamino K, Althoff GH, Bellmann B. Dose-response relationship of fibrous dusts in intraperitoneal studies. Environ Health Perspect. 1997;105(Suppl 5):1253–6.
Wagner JC, Berry G, Skidmore JW, Pooley FD. The comparative effects of three chrysotiles by injection and inhalation in rats. IARC Sci Publ. 1980;30:363–72.
Davis JM, Jones AD. Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol. 1988;69(5):717–37.
McDonald JC, Armstrong B, Case B, Doell D, McCaughey WT, McDonald AD, et al. Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer. 1989;63(8):1544–7.
Kogan FM, Vanchugova NN, Frasch VN. Possibility of inducing glandular stomach cancer in rats exposed to asbestos. Br J Ind Med. 1987;44(10):682–6.
Pott F. Neoplastic findings in experimental asbestos studies and conclusions for fiber carcinogenesis in humans. Ann N Y Acad Sci. 1991;643:205–18.
Collegium-Ramazzini. The 18th Collegium Ramazzini statement: The global health dimensions of asbestos and asbestos-related diseases. Scandinavian journal of work, environment & health. 2016;42(1):86–90.
Davis JM, Coniam SW. Experimental studies on the effects of heated chrysotile asbestos and automobile brake lining dust injected into the body cavities of mice. Exp Mol Pathol. 1973;19(3):339–53.
Woitowitz H-J, Rödelsperger K. Chrysotile Asbestos and mesothelioma. Am J Ind Med. 1991;19(4):551–3.
Pott F. Asbestos use and carcinogenicity in Germany and a comparison with animal studies. The Annals of occupational hygiene. 1994;38(4):589–600 420.
Lemen RA. Asbestos related disease in the United States. La Medicina del lavoro. 1995;86(5):411–25.
Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86(2):179–86.
Wang X, Yano E, Lin S, Yu IT, Lan Y, Tse LA, et al. Cancer mortality in Chinese chrysotile asbestos miners: exposure-response relationships. PLoS One. 2013;8(8):e71899.
Bernstein DM, Rogers RA, Sepulveda R, Kunzendorf P, Bellmann B, Ernst H, et al. Evaluation of the fate and pathological response in the lung and pleura of brake dust alone and in combination with added chrysotile compared to crocidolite asbestos following short-term inhalation exposure. Toxicol Appl Pharmacol. 2015;283(1):20–34.
Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001;39(2):150–60.
Bignon J, Brochard P, Sebastien P. Asbestos pathology: clinical aspects epidemiological data and prevention. Schweiz Med Wochenschr. 1982;112(6):177–85.
Dodson RF, Atkinson MA. Measurements of asbestos burden in tissues. Ann N Y Acad Sci. 2006;1076:281–91.
Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ. 1980;30:237–46.
NIOSH. Report to congress on workers’ home contamination study con-ducted under the workers’ family protection act (29 U.S.C. 671a). Cincinnati,Ohio: U.S.Department ofHealth and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health; 1995.
Finkelstein MM. Reanalysis of non-occupational exposure to asbestos and the risk of pleural mesothelioma. Occup Environ Med. 2018;75(6):472–3.
Finkelstein MM. Malignant mesothelioma and its nonasbestos causes. Archives of pathology & laboratory medicine. 2019;143(6):659–60.
Hodgson JT, Darnton A. Mesothelioma risk from chrysotile. Occup Environ Med. 2010;67(6):432.
Silverstein MA, Welch LS, Lemen R. Developments in asbestos cancer risk assessment. Am J Ind Med. 2009;52(11):850–8.
ICA. For environmental occupational health safe and responsible use 2020 [Available from: https://chrysotileassociation.com/news/n_list.php.
ICA. For environmental occupational health safe and responsible use [Available from: https://chrysotileassociation.com/about.php.
Woitowitz H-J, Baur X. Asbestos-induced lung cancer in Germany: is the compensation practice, in accordance with the epidemiological findings? Collegium Ramazzini, annual Ramazzini days; Carpi, Italy2014.
Baur X. Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation. Int J Environ Res Public Health. 2018;15(1).
Terracini B, Mirabelli D, Baur X, Landrigan P, Collegium R. Comments on the causation of malignant mesothelioma: rebutting the false concept that recent exposures to asbestos do not contribute to causation of mesothelioma. Am J Ind Med. 2016;59(6):506–7.
Gilham C, Rake C, Hodgson J, Darnton A, Burdett G, Peto Wild J, et al. Past and current asbestos exposure and future mesothelioma risks in Britain: the inhaled particles study (TIPS). Int J Epidemiol. 2018;47(6):1745–56.
Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10(5):453–4.
Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990;142(4):843–7.
Vainio H. Epidemics of asbestos-related diseases--something old, something new. Scand J Work Environ Health. 2015;41(1):1–4.